Drugs

Order of the Supreme Court regarding ART drugs for people living with HIV/AIDS, 24/02/2025

Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …

Overdose of paracetamol can be fatal

If you have the habit of popping down paracetamol every time you suffer from cold, fever or flu, beware. The overdose of this most popular family drug can be fatal to the patients habitual of consuming it daily, a study has revealed. Conducted by British researchers, the study says that …

Committee on clinical drug trials submits report

Bhopal : A report on clinical drug trials was submitted to Minister of State for Medical Education (independent charge) Mahendra Hardia here today. Chairman of the committee constituted in this connection and Principal Secretary Medical Education I.S. Dani and members including former Vice-Chancellor of Devi Ahilya Vishwavidyalaya Dr. Bharat Chhaparwal, …

F.D.A. Revokes Approval of Avastin for Use as Breast Cancer Drug

The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling on an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials. The commissioner, Dr. Margaret A. Hamburg, said that …

Catastrophic payments and impoverishment due to out-of-pocket health spending

Out-of-pocket payments are the principal source of healthcare finance in most Asian countries, and India is no exception. This fact has important consequences for household living standards. In this paper the author explores significant changes in the 1990s and early 2000s that appear to have occurred as a result of …

Health ministry plans robust policy to recall faulty, banned drugs

The health ministry is planning to develop a foolproof mechanism to ensure recall of all faulty and banned drugs from the Rs 60,000-crore domestic pharmaceutical market. The move will strengthen the existing recall provisions under the Drugs and Cosmetic Rules. The current law, however, fails to prescribe time-bound recall formats. …

Prices of 348 essential drugs to be controlled

New Delhi: The Centre on Thursday responded to the Supreme Court’s concern over spiralling prices of essential medicines and promised to do all it could to put under a strict price control regime all 348 drugs included in the National List of Essential Medicines (NLEM), 2011. A bench comprising Justices …

Now cancer vaccine awaits human clinical trial

Trials to be conducted in Chennai and United States A therapeutic vaccine against cancer could well be on the way. After successfully undergoing animal tests, it is all set to undergo human clinical trial in a few months. The vaccine, developed by scientists at the National Institute of Immunology (NII) …

FDI Curbs in Pharma Could Deter MNCs: Pfizer India MD

India’s attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country, the head of Pfizer India has warned. “India might not become attractive market if we have such controls, you will see companies pulling out of India,” Kewal Handa, the managing …

Ranbaxy's malaria drug awaits international nod

Even as India’s largest drug maker, Ranbaxy, is confident of launching its first “new drug” by January 2012 to combat malaria in the country, the global euphoria the potential drug had generated in the initial stages of its research seems missing. Health experts attribute this to the absence of international …

Pfizer Marketing May Hit Ranbaxy Earnings from Lipitor Clone

Aggressive marketing initiatives by Pfizer Inc may reduce Ranbaxy Laboratories’ earnings from the scheduled launch of its lowcost version of Lipitor, the world’s largest selling drug, in the US by the month end. The world’s largest drugmaker earns around $6 billion from Lipitor sales in the US and it has …

The modest woman who beat malaria for China

The origins of our best drug against malaria have long been a mystery. Meet Tu Youyou, who scoured ancient Chinese medical texts for the cure.

Challenge of controlling and preventing diabetes

Even as modern medicine practices have elaborate programmes for diabetes control and prevention programmes with diet charts and exercises, there is but little focus on the crucial component of stress, which is considered an important contributing factor for diabetes, said Harish Kumar, head of endocrinology, Amrita Institute of Medical Sciences. …

Clinton to Urge Using Latest Science in New AIDS Push

Secretary of State Hillary Clinton is expected to call Tuesday for a new push by the U.S. and other countries to harness recent science to stem the HIV/AIDS pandemic. Government researchers believe science has now developed sufficient tools to contain the pandemic, which erupted 30 years ago, has infected more …

High spending on medicines, health to push Indians into poverty, says WHO

High spending on medicines and health will push many Indians below the poverty line, the World Health Organisation has cautioned. “Due to the out-of-pocket spending of their income on medicines and healthcare services, about 3.2 per cent of India's population will come below the poverty line,” a senior WHO official …

Vaccine policy and advance market commitments

The new National Vaccine Policy Draft 2011 by the Union Ministry of Health and Family Welfare comes out openly in favour of public-private partnerships and suggests flexible governing and funding mechanisms to support vaccine development in the PPP mode. This article argues that our vaccine policy must look into the …

New Policy to Force Cut in Imported Drug Prices

Foreign drugmakers fear they would be forced to cut prices of imported medicines by up to 90% A key clause in the government’s draft drug pricing policy has raised the hackles of foreign drugmakers who fear it could force them to sharply reduce prices of several imported medicines by up …

Health care costs pushing Indians below poverty line: WHO

NEW DELHI, 1 NOV: Out-of-pocket spending of their income on medicines and health care services due to rising cost of diagnosis, medicines and hospitalisation will push millions of Indians (about 3.2 per cent) below the poverty line, said World Health Organisation (WHO) experts here today. More than 40 per cent …

Indians’ medicine bills concern WHO: 70% Spend Entire Income On Treatment

New Delhi: The World Health Organization (WHO) is worried about Indians’ high out-of-pocket (OOP) expenses to buy medicines. WHO says, 3.2% Indians will fall below the poverty line because of high medical bills. About 70% of Indians spend their entire income on healthcare and purchasing drugs, WHO suggests. Dr Kathleen …

Ranbaxy Gets Nod for Ist Drug Developed by Indian Pharma Co

The country’s drug regulator has given conditional market approval for Ranbaxy Laboratories’ anti-malaria drug, paving the way for the launch of the country’s first privately-developed medicine and ending more than a decade of failures or near misses for India’s drug makers While the domestic drug industry has been successful in …

Pneumonia progress report 2011

Pneumonia killed more children than any other disease in 2008, according to the World Health Organization (WHO). This report examines steps being taken to prevent this illness in the 15 countries with the highest pneumonia death toll among young children. Together, these countries account for approximately 75 percent of the …

  1. 1
  2. ...
  3. 60
  4. 61
  5. 62
  6. 63
  7. 64
  8. ...
  9. 151

IEP content by date loading...
IEP child categories loading...